RNU6-1108P

Across TCGA pan-cancer cohorts, RNU6-1108P RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated RNU6-1108P data layer.

The strongest signal is observed in thyroid carcinoma (THCA), where higher RNU6-1108P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU6-1108P expression acts as an unfavorable survival marker.

THCA and COAD are the cancer types where RNU6-1108P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
THCA	DFS	Tertile	All	0.027	0.945	<.001	72	view →
COAD	OS	Tertile	All	0.054	0.871	<.001	54	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

RNU6-1108P–THCA (DFS)

Open the THCA breakdown →